1. Technology for Augmenting Type 1 Diabetes Mellitus Management
- Author
-
Michelle Condren, Samie Sabet, Jenna Hopwood, Laura J. Chalmers, and Taylor Saley
- Subjects
medicine.medical_specialty ,Type 1 diabetes ,business.industry ,Continuous glucose monitoring ,Insulin ,medicine.medical_treatment ,Review ,medicine.disease ,Glucagon ,Continuous subcutaneous infusion ,Pediatrics, Perinatology and Child Health ,Medicine ,Pharmacology (medical) ,business ,Intensive care medicine ,human activities - Abstract
Type 1 diabetes mellitus has witnessed significant progress in its management over the past several decades. This review highlights technologic advancements in type 1 diabetes management. Continuous glucose monitoring systems are now available at various functionality and cost levels, addressing diverse patient needs, including a recently US Food and Drug Administration (FDA)–approved implantable continuous glucose monitoring system (CGMS). Another dimension to these state-of-the-art technologies is CGMS and insulin pump integration. These integrations have allowed for CGMS-based adjustments to basal insulin delivery rates and suspension of insulin delivery when a low blood glucose event is predicted. This review also includes a brief discussion of upcoming technologies such as patch-based CGMS and insulin-glucagon dual-hormonal delivery.
- Published
- 2019